Clinical Trial Update: AZD1775 for Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial update for AZD1775 in advanced solid tumors has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• AZD1775 (Adavosertib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Solid Tumors | Phase 1 | Status: COMPLETED | Results posted: 2021-07-26